Dr. Boen

Entrepreneurship
in
Health Care.

Opportuni3es for the Health Care

professionals/Medical doctors
Boenjamin Setiawan, dr, PhD.

Founder and Honorary Chairman
PT Kalbe Farma, Tbk.
28 Febr, 2016, Workshop ILUNI
FKUI
Entrepreneurship in Health Care
23 February, 2016, CIMB

Leadership series
BS, ppt, Entrepreneurship, Kalbe Farma,

2016
Short History of Kalbe Farma

1. The Trigger that started Kalbe Farma,
1963-1966
2. Key Success Factors, 1966-1977
3. DiversicaRon period, 1977-1994
4. ConsolidaRon and Pre-crisis, 1995-1998
5. Crisis and Survival, 1998-2007
6. Act Local, Go Regional, Think Global
and MOVE FAST 2007-2020
FKUI
History of Company
Founded in September 10, 1966.
Started its operaRon in a modest garage at
Jalan Simpang I No. 1, Tanjung Priok.


FKUI
DistribuRon Network developed so fast that by 1974 (8 years

a_er establishment) distribuRon in the whole Country was
pracRcally covered.
The Company moved from the old premises to Jalan Jendral
A. Yani (Pulomas).

FKUI
10 Companies that started in a garage

1. Harley Davidson, In 1901, 21-year-old William S. Harley drew up plans to
create a small engine to power a bicycle.
2. Disney, started by Roy and Walt Disney in 1923
3. HewleI-Packard, Bill HewleI and Dave Packard In 1939, founded HP in
Packards garage with an ini3al investment of $538
4. MaIell, Harold Mab Matson and Elliot Handler founded Mabel out of a
garage in Southern California as picture frame company in 1945, Today Mabel,
Inc. is the highest-grossing toy company in the world.
5. Lotus cars, In 1948, at the age of 20, Anthony Colin Bruce Chapman started
Lotus Cars
6. Maglite, In 1955, a_er saving $125, Tony put a down-payment on his rst
lathe. Then he started working out of a Los Angeles area garage to manufacture
precision parts. He incorporated Mag Instrument in 1974 and released their rst
ashlight in 1979.
7. Yankee Candle Company, In 1969, at 16 years old, Michael KiIredge made his
scented candle in his garage out of melted crayons as a gi_ for his mother.
8. Apple started in 1994 by Steve Jobs (21) and Steve Wozniak (26)
9. Amazon, was set up by Je Bezold in September 1994,
10. Google, Larry Page and Sergey Brin ,as Stanford students, in 1999 started
w
hats
known
28
Febr,
2016, n
Wow
orkshop
ILUNI as Google from Susan Wojcickis garage
FKUI
Amazon, started by Je Bezos
Apple started in 1976 by
Steve Jobs and Steve Wozniak
founded Amazon.com in 1994

FKUI
#3 Disney
About 45 minutes down the road from Disneyland Park in Anaheim, CA, theres a house
in Los Angeles where The Walt Disney Company got its start.
In 1923, the house belonged to Walt Disneys uncle, Robert Disney. Walt and his brother
Roy moved in with their uncle and set up The First Disney Studio in the one-car garage
out back. There they started lming the Alice Comedies which was part of the original
Alices Wonderland.
Today, Disney is the highest-grossing media conglomerate in the world.
Address: 4651 Kingswell Ave, Los Angeles, California
#4 Google
As Stanford Graduate students, Larry Page and Sergey Brin started whats now known
as Google from Susan Wojcickis garage in September 1998.
Soon the project was interfering with their schoolwork, so they tried to sell it to Excite for
$1 million. Excite rejected the oer and now Google is the most tracked site in the
world.
Address: 232 Santa Margarita Ave, Menlo Park, California
FKUI
#6 HewleI-Packard
In 1939, Bill HewleI and Dave Packard
founded HP in Packards garage with an
ini3al investment of $538.
Their rst product was an audio oscillator
and one of their rst customers was Walt
Disney, who purchased eight oscillators
to develop the sound system for the
movie Fantasia.
The HP Garage in Palo Alto is known as
the birthplace of the largest company in
the world of Silicon Valley.
Address: 367 Addison Ave, Palo Alto,
California


FKUI
Key Success Factors of Kalbe Farma

Keluarga yg bersatu dan
kerja keras adalah KUNCI
keberhasilan se*ap USAHA
Harus selalu
diperha*kan
KELUARGA
ANUGERAH
Harus DILIHAT,
DITANGKAP dan
DIMANFAATKAN
Peluang/Kesempatan
dari anugerah
KEBETULAN
OPPORTUNITY
Memegang peran
pen*ng dalam
kehidupan
Teman/Kolega/Kenalan
hanya bermanfaat bilamana
ada INTEGRITAS
HOKI
FKUI
NETWORKING
7 KEBETULAN
1. Sewaktu jaman Jepang saya 3dak sekolah selama 2 tahun dan saat
melihat teman sekolah, saya merasa MINDER
2. Perasaan MINDER memacu saya untuk selalu berusaha menjadi
NOMOR SATU disekolah maupun dalam PEKERJAAN
3. Saya dapat kesempatan ke USA untuk mengambil PhD di UCSF dalam
rangka kerjasama FKUI-University of California San Francisco
4. Sekembali dari USA saya ingin melanjutkan peneli3an dan berusaha
meminta dana peneli3an dari pak Wim Kalona, pemilik/direktur
PT.DUPA dan saya dengan mudah mendapatkan dana peneli3an
sehingga tercetus KEINGINAN untuk mendirikan USAHA FARMASI
5. Setelah dua kali gagal untuk mendirikan usaha farmasi dengan
beberapa teman dokter maka sewaktu drg Se3ady mengunjungi saya di
rumah UI dan melihat saya mau ke Belanda untuk bekerja di
Enzypharm maka dia mengusulkan supaya tetap di Indonesia dan
bersama Sdr. lain bersama-sama berusaha mendirikan usaha farmasi
6. Tahun 1966 jaman Suharto merupakan waktu yang TEPAT karena
Industri Farmasi PMA mulai masuk Indonesia
28 SFaudara
ebr, 2016, BWertekad
orkshop ILUNI
7. 6
dan Bersatu untuk
membangun
Industri
Entrepreneurship
in Health
Care Kesehatan
FKUI
Filoso Perusahaan Kunci Menuju Sukses

(S.S.S.I.P.), 1966-2009
1.
2.
Falsafah perusahaan merupakan dasar existensi dan sudah

mencakup visi dan misi perusahaan
Falsafah Kalbe Farma adalah sebagai berikut:
1. Tujuan perusahaan adalah Survival through Growth

and Adapta3on
2. Perusahaan harus mampu terus survive untuk para
Stakeholders
3. Perusahaan mampu survive karena: Kwalitas SDM

nya harus DJITU, C10, PBFWUSI
4. Terus mampu mengembangkan IPTEK, melalui
INNOVASI
5. Menganut strategi Par3cipa3ve and Professional

28 Febr, 2Innova3ve
016, Workshop ILUNI Management
FKUI
Panca Srada Kalbe Farma 1966-2009

S
S
S
Kalbe harus Survive dengan TUMBUH KEMBANG terus menerus

Kalbe dapat terus Survive untuk para Stakeholders, yaitu, Pemegang
Saham, Karyawan, Konsumen, Suppliers, Distributor, Bankers, Pemerintah dan
Masyarakat luas.
SDM: Manusia DJITU, PBFWUSSI merupakan Kunci Utama untuk dapat

Survive dalam lingkungan yang terus berubah
Inovasi IPTEK merupakan KUNCI KEMAJUAN dan Survival
Manajemen Par3sipa3f dan Profesional adalah keharusan untuk

dapat Survive.

FKUI
Panca Srada Kalbe Farma 2009 now

T.M.I.S.I
Trust is the glue
Mindfulness in
of life

the founda3on of
our ac3on
Strive to be the
best


FKUI
Innova3on is the
key to our success

Interconnectedness
is a universal way of
life
What were the Reasons for Success??

1. The RIGHT 3me, because in 1966 the Suharto Gov.
opened the doors for foreign investment.
2. The RIGHT products and RIGHT pricing, because
as a pharmacologist and pracRsing physican I
knew the needs of doctors
3. The RIGHT marke3ng strategy, following the
footsteps of the foreign companies by promoRon
through Medical Reps.
4. The RIGHT company strategy by Professionalizing
our team from the beginning
5. The RIGHT and BRIGHT people to run the
company
FKUI

In 1977 within 11 years, the Company was able to

become the largest pharmaceu3cal company in
Indonesia (IMS report).
In 1991 the Company became a public company and
listed on the Jakarta Stock Exchange and Surabaya
Stock Exchange.
Now in 2014 we have over 17,000 employees and a
marke3ng and sales force of 6,000 covering 80% of
the Indonesian consumer health and 100% of the
Indonesian prescrip3on pharmaceu3cal market.
FKUI
Faktor UTAMA yang menentukan Kemajuan

Perusahaan = SDM
1. KWALITAS Pimpinan dan Karyawan
2. Yang paling penRng IQ, EQ, SQ, SQ, LQ, PQ
3. Manusia DJITU
4. Manusia C 10
5. Manusia PBFWUSSI
6. Strategi 5C
7. Strategi 5S, etc.

Contoh: ASTRA, Indofood, Apple, Google, Microso_,
Roche, Pzer, Glaxo-Smith etc.
FKUI
Manusia D.J.I.T.U
D Disiplin dan Dedikasi
J Jujur dan Jeli
I Inova3f dan Inisia3f
T Tanggung jawab dan Tulus
U Unggul dan Ulet
FKUI
MANUSIA PBFWUSSI (The 8th Habit
of Highly Eectve People, Stephen R.Covey)
1.
2.
3.
4.
5.
6.
7.
8.
PROACTIVE
Begin With the END in MIND
First Things First (PrioriRze)
WIN-WIN
Understand to be Understood
SYNERGIZE
Sharpen the Saw
Inspire yourself and others to nd their VOICE

FKUI
Technopreneur
They are entrepreneurs who used
technology as their driving factor
in transforming resources into
goods and services, creaRng an
environment conducive to industrial
growth
FKUI
Entrepreneurial Traits (1)

Most Important for Success:

1. InnovaRve & Looking for Opportuni3es

2. Willingness to take risk
3. Ini3a3ve
4. Self reliance
5. Perseverance (keep trying to achieve something)
6. Need to achieve
7. Self condence


FKUI
Entrepreneurial Traits (2)

Important for Success:

1. Leadership
2. Compe33veness
3. Good physical health
4. Crea3ve
5. High level of energy
6. Versa3lity
FKUI
Dierence Between Entrepreneurship

And Small Business
Entrepreneurship
Small Business
InnovaRon
Lible innovaRon
Fast growth
StaRc growth
Vision
Lible vision
Employment creaRon
Money making machine
Higher risk
FKUI
Family business
Earning a livelihood
Low or minimum risk
Entrepreneurship Sta3s3cs
Do You Know?
US Situa3on 2010
About 1 million businesses are formed each year in the US
Between 70 to 80% failed the rst year of start-up
10% to 20% last through the next 5 years
Venture investment 1:10 success rate
Venture capitalists expects between 5 to 10 3mes return

Source
S Sta3s3cs
28 Febr, :2 U
016,
Workshop ILUNI
FKUI
1.
2.
3.
4.
5.
6.
Trend Pengembangan Industri Farmasi

Dunia
Gelombang pertama adalah penggunaan obat asal tanaman,

binatang dan mineral
Gelombang kedua adalah penggunaan OBAT SINTETIK
setelah penemuan Paul Ehrlich (Bapak Kemoterapi) bahwa
berbagai zat warna melekat pada reseptor spesik
Gelombang keRga terjadi dengan penemuan berbagai
ANTIBIOTIKA
Gelombang keempat adalah penemuan berbagai obat
BIOPHARMACEUTICALS, erythropoeRn, interferron, dsb
melalui geneRc engineering
Sekarang akan terjadi gelombang kelima dengan
ditemukannya STEM CELL dan kita akan memasuki
KEDOKTERAN REGENERATIF
Indonesia harus lompat dan langsung masuk gelombang

keempat dan kelima

FKUI
Act Local, Go Regional

(ASEAN) ,THINK GLOBAL and MOVE
FAST
1. PT Kalbe Farma is NOW the number one Pharma

Industry in Indonesia
2. Go Regional, now we must aim to become
number one in all the ASEAN countries
3. The next step is to think and become a GLOBAL
PLAYER
4. All this can only be achieved if we have the BEST
and the BRIGHTEST PEOPLE in our company
5. R&D on CANCER and STEM CELL research must
be prioriRzed for Immunotherapy of CANCER and
DegeneraRve Diseases
28 Febr, 2016, Workshop ILUNI FKUI
Jend. Ahmad Yani No.2

Pulomas, Jakarta 13210
Indonesia
Website : www.sci-indonesia.id
FKUI
Background
Established
December 1ST, 2006
Founded by
Boenjamin Se3awan, MD, PhD
Mission
To Conduct Transla*onal STEM CELL & CANCER Research
Through Developing Innova*ve and Mul* Disciplinary
Collabora*ve Approaches to Improve the Quality of Life
in Ethical and Responsible Manner.

FKUI
AcRviRes
Research & Development Projects

PublicaRon in ScienRc InternaRonal Journal
IRB (InsRtuRonal Review Board) & SAB (ScienRc Advisory Board), annually
CollaboraRon with strategic partner & InsRtuRon, both in Indonesia & InternaRonal
Academic Counselor for postdoc program

Clinical trial
ApprenRce program
ScienRc Events
OsteoarthriRs, Ciptomangunkusumo Hospital (2013)

Mal-union bone fracture, Ciptomangukusumo Hospital (2013)
Myocardial infarcRon, Harapan Kita Hospital (2013)
Doctor Boenjamin SeRawan DisRnguish Lecture Series, on September, annually (since 2013)
Journal club review, monthly
In planning 2016 : Genomic forum, collaboraRon with i3L
AcRvely involved (members) in the Stem Cells regulaRon (Ministry of Health & BPOM) &
Research AssociaRon
NaRonal Commibees of Stem Cell Indonesia (Ministry of Health)

Indonesia Stem Cell ConsorRum
Asosiasi Sel Punca Indonesia (ASPI)

FKUI
R&D
Current Projects
Stem Cell Projects
Wharton Jellys Mesenchymal Stem Cell (allogenic)

Adipose Mesenchymal Stem Cell & Stromal Vascular Frac>on (autologous)
Condi>oned Media
Cancer Projects
Liquid Biopsy Projects

Kit Diagnos>c for Cancer Biomaker
New Biomaker in Cancer & Predic>ve Diagnos>c
Immunology
HBV & HPV oral vaccine

CANCER Immunotherapy
Nanotechnology Project
Nano Chitosan for wound

Nano aurum for Cancer Diagnos>c & Therapeu>c

FKUI
Pre / Clinical Trial Plan

Wharton Jellys MSC
OsteoarthriRs
Diabetes mellitus
AnR Aging
Stroke
Cerebral Palsy
Spinal Cord Injury
Nano Chitosan
Wound care and CosmeRcs

FKUI
Strategic Partners
Indonesia
Interna3onal
University
Universitas Indonesia
InsRtut Pertanian Bogor
Universitas Gadjah Mada
InsRtut Teknologi Bandung
Universitas Padjajaran
Indonesia InternaRonal InsRtute
for Life Sciences (i3L)
Hospital
University
Karolinska, Sweden
Hospital
Cipto Mangukusumo
FatmawaR
Jantung Harapan Kita
RS Hasan Sadikin
NUS Singapore
Research InsRtuRon
LIPI (Lembaga Ilmu Pengetahuan

Indonesia)
BPPT (Badan PeneliRan dan
Pengembangan Teknologi)
BATAN (Badan Tenaga Atom
Nasional)
Company
Biopharma, Bandung

FKUI
Company
Stemedica, San Diego, US

DNALab, Malaysia
ScienRc Advisory Board

Professor Astar Winoto, PhD
Professor of Immunology & Pathogenesis

Director of Molecular & Cell Biology & Cancer Research Laboratory
University of California, Berkeley
Professor Yufang Shi, PhD
Director of InsRtute of Health Sciences Laboratory of Immunology & Adult Stem

Cell
Shanghai InsRtute for Biological Sciences, China
Professor Wen-Hwa Lee, PhD
Professor of Biomedicine, University of California, Irvine School of Medicines

Department of Biological Chemistry
Chancellor China Medical University, Taiwan
Professor Shen Ding, PhD
Professor of PharmaceuRcal Chemistry, University of California, San Francisco

Senior InvesRgator, Gladstone InsRtute of Cardiovascular Disease

FKUI
RecogniRon
Indonesias 1st Registered Stem Cell Processing Laboratory (2013)
License CerRcate, Ministry of Health
cGMP (2014)
BPOM cerRcaRon for Allogenic Stem Cell Mfr
OCI (2015)
Outstanding Corporate Innovator, PDMA, PPM, Swa
Silver Award, InnovaRon + CreaRvity : Indonesia Reinvented
New Product Development Award
ISO, KAN & InternaRonal Prociency test for Kalgen Laboratory

(annually)

FKUI

FKUI
Global Healthcare Expenditure 2010-2020
Notes: * Report Frost & Sullivan lain menyebutkan Indonesia healthcare

expenditure di tahun 2018 mencapai USD 60,6 bn dengan CAGR 14,9%

FKUI
Source: Globaliza3on of IVD Markets, Frost & Sullivan , 2013
PROSPEK TAHUN 2016 BAGI PRODUSEN FARMASI DI ASIA (exc. JAPAN)

TERLIHAT SANGAT POSITIF DIPERKIRAKAN MENCAPAI US$ 230 BN
(19% DARI PASAR FARMASI GLOBAL)

Total World Market of pharmaceu3cals 2014, 1.1 Trillion USD
Asia w/o
Japan
19%
Japan
13%
North
America
31%
Rest of Western
World Europe
19%
19%

FKUI
Source: IMS Asia Pacic Insight, IMS ,2013
1. The Global Health Care Industry

1.1. The global Health Care industry is one of the world's fastest
growing industries, absorbing over 10% of gross domes3c product of
most developed na3ons.
It consRtutes of broad services oered by various hospitals, physicians, nursing homes,

diagnosRc laboratories, pharmacies and ably supported by drugs, pharmaceuRcals, chemicals,
medical equipment, manufacturers and suppliers.
The medical and health care industry provides enormous employment opportuni3es to
choose from. Apart from using the services of medical professionals, this industry also uRlizes
the expert services of public policy workers, medical writers, clinical research lab workers, IT
professionals, sales/markeRng professionals and health insurance providers.

1.2. SIZE OF THE INDUSTRY
The United States of America has one of the largest medical and healthcare industries in the
world, followed by Switzerland and Germany. The USA's medical industry comprises of more
than 750,000 physicians and 5,200 hospitals. USA witnesses approximately 3.8 million
inpaRent visits and 20 million outpaRents visit on a daily basis. Furthermore, the United
States of America has the largest workforce i.e. one in every 11 US residents employed in the
health care business.
FKUI
The Global Health Care Industry

1.3. The global healthcare industry market is forecast to reach $7
trillion in 2012 (10% of world GDP), according to research from
Global Industry Analysts. Investment in sectors such as home
healthcare, healthcare IT and telehealth are expected to conRnue
fuelling market expansion. Due to the worlds aging populaRon, the
demand for home healthcare is likely to conRnue climbing over the
years to come.
1.4. The healthcare services industry is labor intensive and
overburdened in many regions, making telehealth and
healthcare IT aIrac3ve op3ons. With medical technologies
conRnually developing, these opRons are proving benecial to
paRents and the overall healthcare system.

FKUI
The US Health Care market
Health Expenditures and Services in the U.S.:
Health care costs conRnue to rise rapidly in the U.S. and throughout the developed
world. Total U.S. health care expenditures were es3mated to be $2.9 trillion in
2013, and are projected to soar to $3.4 trillion in 2016.
The health care market in the U.S. in 2013 included the major categories of
hospital care (about $929.0 billion), physician and clinical services ($588.8 billion),
dental services ($116.6 billion) and prescrip3on drugs ($262.3 billion), along with
nursing home and home health ($238.6 billion). Registered U.S. hospitals totaled
5,724 properRes in 2011, according to an American Hospital AssociaRon survey,
containing 924,333 beds serving 36.5 million admibed paRents during the year.
Medicare, the U.S. federal governments health care program for Americans 65
years or older, provided coverage to 50.7 million seniors in 2013. NaRonal
expenditures on Medicare for scal 2013 were projected to be $604.2 billion,
including premiums paid by beneciaries. By 2030, the number of people covered
by Medicare will balloon to about 78.0 million due to the massive number of Baby
Boomers entering reRrement age.

FKUI
GLOBAL SPENDING ON MEDICINES

Annual global spending on medicines will reach nearly $1.2 trillion by 2016, as the
pharmerging markets, biologics and generics contribute more to spending.
In the developed markets, including the United States, Europe and Japan, spending will decline
to 57% of the global total due to expiring patents for a number of signicant brand-name drugs,
slower increases in spending on branded products, and increased cost containment measures
by payers.

Alterna3vely, pharmerging markets will reach 30% of global spending by 2016, as popula3on
and economic growth contribute to drama3cally higher use of medicines in these markets.
Overall, the top 20 therapy areas will account for 42% of global spending, led by cancer,
diabetes and asthma/COPD.

An accelerated shiq to the use of generic medicines is expected, both from an unprecedented
level of patent expiries in the U.S., and from volume-driven growth in the largely generic-using
pharmerging markets. At the same Rme, lower-cost versions of expensive biologic medicines, or
biosimilars, will conRnue to be launched, though slowly, and will account for only $4-6Bn, or 2%,
of the $200-210Bn in spending on biologics by 2016.

FKUI
Opportuni3es in ASEANs Healthcare Sector

Healthcare in ASEAN
The AssociaRon of Southeast Asian NaRons (ASEAN) is a geo-poliRcal and economic organisaRon
comprising of Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar,
Cambodia, Laos and Vietnam. Established in 1967, the group has been instrumental in
promoRng the regions economic growth and development. CollecRvely, the group has
established economic links and entered into free trade agreements with various countries
including China, Japan, South Korea, India, Australia and New Zealand.
With a combined nominal GDP of over 2.3T USD, ASEAN as a bloc is presently the
eighth largest economy in the world.
In recent Rmes, despite weak economic condiRons in the US and EU as well as slowing growth in
China, the ASEAN economy has maintained its robust growth trajectory. When the ASEAN
Economic Community (AEC) will be implemented in 2015, the common economy is

expected to join the ranks of China and India as a major economic growth force in
Asia.
Healthcare is a priority sector that the ASEAN governments have idenRed for region-wide
integraRon. The upcoming AEC formaRon is expected to further accelerate the growth of the
regions healthcare industry, driven by addiRonal foreign direct investments, freer ow of
trade, manpower and capital within ASEAN, and growing auence among ASEAN countries.
Table 1 below provides a rough indicaRon of the overall potenRal size of the AEC market.

FKUI
ASEAN OpportuniRes in Health Care

FKUI
ASEAN Total PopulaRon Growth rate and GDP

2012

FKUI

FKUI
The Outlook for Medical Tourism in Asia
December 2012 An interes3ng ar3cle recently came out declaring

that medical tourism in Asia could reach USD 8.5 billion by the end of
next year. [1] This is a very impressive gure but according to recent
es3mates by McKinsey & Co., worldwide medical tourism is a USD
100 billion industry [2], a gure which leaves Asia ample opportunity
to catch up and grow further.
Likewise, research rm, Global InformaRon Inc., elaborated in its report
that Thailand and India have been dominaRng the industry for quite
some Rme, while the Philippines, Malaysia, Singapore and South
Korea have put in place government-supported medical tourism
programs to capitalize on this growing industry. Case in point, Singapore
and Malaysia have been posRng double digit annual compound growth rates of 11.9
and 29.3 percent respecRvely, in terms of internaRonal paRent arrivals for the past
couple of years. Unfortunately INDONESIA is leq behind
FKUI
Medical Tourism
So what could be the factors fueling this rapid growth? Advancements
in service delivery models and medical technology, rise of low-cost travel,

extensive tourism infrastructure and the evolving methods of medical marke3ng
through social media are emphasized by analysts as the main elements that aect
the decision for oshore medical care. These factors con3nually lure cost-
conscious pa3ents with the consola3on of exploring Asia, since the bargain of
combining cost-eec3ve treatment and travel in one airline 3cket is hard to beat.
With spiraling medical costs in the United States and to a certain

extent, Europe's bleak economic outlook, pa3ents are now looking
elsewhere for medical treatments. The US Medical Tourism
Associa3on compared the actual costs for specic medical
procedures in various countries including some in Southeast Asia.
The data below highlights the disparity between Asian countries and
the United States when it comes to cost of certain treatments.

FKUI
Cost comparison for selected surgeries, 2007

Surgery

U.S.

India
Thailand
Singapore
1.Heart bypass

$130,000
$10,000
$11,000
$18,500

2. Heart valve
$160,000
$9,000
$10,000
$12,500
replacement
3. Angioplasty
$57,000
$11,000
$13,000
$13,000

4. Hip replacement $43,000
$9,000
$12,000
$12,000

5. Hysterectomy
$20,000
$3,000
$4,500
$6,000

6. Knee replacement $40,000
$8,500
$10,000
$13,000

7. Spinal fusion $62,000
$5,500
$7,000
$9,000

Source: American Medical AssociaRon, June 2007,
available at: hbp://www.medicaltourism-guide.com/2008/04/03/cost-comparison/
FKUI

FKUI
Indonesias Health Spending Trends
Low healthcare expenditure to GDP ra3o.
Na3onal Health Insurance (Jaminan Kesehatan

Nasional or JKN) program has commenced in January
2014, and covered more than 50% of the popula3on
in 2014. JKN targets to cover the en3re Indonesian
popula3on by 2019.
Healthcare Expenditure/GDP 2013 (%)

United States
18.0%
United Kingdom
9.6%
Singapore
5.8%
China
5.5%
Malaysia
4.3%
Thailand
4.2%
India
4.1%
Indonesia
Total Healthcare Expenditure

(USD Bn)
30.4
CAGR
12.5%
3.3%
Source : Centers for Medicare & Medicaid Services, Oce of the Actuary; United Kingdom : Healthcare
Report, Economist Intelligence Unit; Kementerian Kesehatan Indonesia, China; Singapore
Government Budget; Economic Survey, India; Frost & Sullivan
JKN Coverage Roadmap
26.4
19.0
12.1
21.1
13.1
23.4
14.5
15.9
18.2
Private Expenditure
Public Expenditure
6.8
7.9
8.9
10.5
12.2
2009
2010
2011
2012
2013
2014
133 mn
people *
Target 170
mn people

2019
Target 250 mn
people
100% coverage
to NaRonal Health Insurance 2012 - 2019

Source : Roadmap
Source : Global Health Expenditure Database, WHO

FKUI
2015
Indonesia 2025
Plans for
Indonesias GDP
Indonesia, melalui MP3EI, mentargetkan sebagai negara maju dengan:
1.PDB

: USD 4,0 4,5 Triliun
2.PDB per kapita

: USD 14.250- 15.500
3.Pertumbuhan ekonomi riil
: 6,47,5% (periode 2011-2014), dan

8,09,0% (periode 2015-2025)
4.
Inasi

: 6,5% (periode
2011-2014)
an 3% (2025)
Entrepreneurship
in Health Cd
are
FKUI
Source: Indonesia MP3EI Report, Bapenas RI, 2011
DI ASEAN, INDONESIA MERUPAKAN PASAR FARMASI TERBESAR

DENGAN PANGSA PASAR USD 9.4 BILLION TAHUN 2018
DAN MASUK KE DALAM TOP 20 GLOBAL RANKING DI TAHUN 2017

FKUI
Source: IMS Asia Pacic Insight, IMS, 2013

FKUI
HEALTHCARE BECOMES PERSONALIZED,

PREDICTIVE AND PREVENTIVE
Healthcare is becoming a precision-based industry
Advancements in
predictive and
preventative
medicine
Patient
segmentation/
tailored treatment
regimens
Genetic Mapping
Personalized
Medicine
FKUI
Source: Frost & Sullivan Analysis.
POTENSI PRODUK FARMASI INDONESIA

DI MASA MENDATANG
Biotechnology & Vaccine
Herbal & Mari3m
Cell Therapy
FKUI
Drug Delivery System

(DDS)
Diagnos3k
(IVD / In-vitro Diagnos3c)
Source: GP Farmasi Discussion, 2013
WHY BIOTECHNOLOGY?
The trend of healthcare leads to personalized
(a product of biotechnology) & prevenRve
medicaRon (vaccine)
GeneRc engineering technology will facilitate
the discovery and the producRon of products
of biotechnology eciently
Indonesia has adequate resources for
biotechnology development:
Blood fracRonaRon Indonesia is the
fourth most populous country globally with
a populaRon of about 249 million.
Biofarma, Bandung R&D supported by
Lembaga Eijkman
FKUI
GLOBAL BIOTECHNOLOGY PRODUCTS

BiopharmaceuRcals is one of the most rapidly growing in the pharmaceuRcals
industry
Biotechnology global market would exceed USD 320 billion in 2015 (Global
Industry Analysis, Inc. 2012)

FKUI
How can we
address these
Global
Challenges?
AWAS
Kepeleset!!!

FKUI
The Dawn of the Knowledge Era

Human Resource Development is the KEY for
IRRADICATING POVERTY
Spectacular developments in science and technology
Unparalleled economic growth globaliza3on, compe33on, innova3on
at the vanguard
Uncontrolled exploitaRon of earths resources, a BIG PROBLEM
21st century will be the century of knowledge
the process of transi3on is on

FKUI
A Renewed Focus on Innova3on

Science and innova3on is
"more essen3al for our
prosperity, our security, our
health, and our environment
than it has ever been."

-President Obama at the Na3onal
AcademiesApril 27, 2009-

FKUI
U.S. Science and Technology Policy

NaRonal Science and Technology
Council (cabinet-level council)
Chaired by the President
A primary objecRve of the NSTC is the
establishment of clear na>onal goals for
Federal science and technology investments
in a broad array of areas

FKUI
Mission of Biotech and Life Science in China

Biotechnology should be our
focus that we catch up with the
advanced level in future high-tech
industry, and its applica3ons should
be strengthened in such elds as
agriculture, industry, popula3on and
health, etc.

- Speech delivered by former president Hu Jin Tao at the
Na3onal Congress of Science and Technology, 2006 -

FKUI
Dominant Role of Engineering

Science and Technology
Biotechnologies will create new areas of
economic growth; gene technology, protein
engineering, space u3liza3on, ocean
development and new energy and materials
will produce a great many innova3on results
that will expand the space for produc3on and
development and increase the standard and
quality of human life.

- Speech delivered by president Xi Jin Ping at the Interna3onal
Conference on Engineering Science and Technology, 2014 -

FKUI

FKUI
Innova3on is the KEY of WEALTH Crea3on

Innova3on is the lifeblood of our global economy and
a strategic priority for all CEOs everywhere. Were all
familiar with classic cases where revoluRonary ideas
upended industries and generated enormous wealth:
1) the Apple iPods outplaying the Sony Walkman;
2) Starbucks beans and atmosphere ooding out
tradiRonal coee shops;
3) Skypes using a strategy of free to unspool AT&T.
4) But how about ReckiI Benckiser Group, the BriRsh
consumer products giant (Lysol, Woolite, Clearasil),
which looks to customers, among others, to nd new
methods to detect parasites?
FKUI
R & D
Innova3on
Idea
People
Tools
Products and
Produc3vity
Goal: Strengthening the Economy

FKUI
Government-University-Industry Partnership
(ABGC)
Promote and
SRmulate
Set R&D Policy and

Provide Funding

FKUI
University
R & D
Resources
Government
Driver
Industry
Products
Government
Conduct research criRcal to naRonal interests
Federal labs (NIST, NREL, Oak Ridge, etc.)
Provide research funding via government agencies
University
Basic and applied research (Open)
Training and prepare future workforce
From ideas to bench-scale prototypes
Industry
Market-driven product research and innovaRon
From ideas to prototypes, to large scale manufacturing
and markeRng

FKUI
If INDONESIA is serious about
compe>ng in the global market, it is

>me to understand the impact of
Science and Technology and
Educa>on on the economy.
One I-phone 5 costs
more than a ton of rice
Innova3on versus Business as Usual
FKUI
Industry-University Coopera3ve Research

Center (IUCRC) USA
Presently, there are 56 IUCRCs working with
170 universiRes and 1100 member organizaRons
Basic Requirements for an IUCRC Center:
Proposed research must be of interest to the Industry
Cost share by the industry
Must have at least 10 industrial partners
Must have a strong group of research universi3es and
researchers in the consor3um

FKUI
Industry-University Coopera3ve Research

Center (IUCRC)
Researchers from partner universi3es
submit ideas and proposals compe3ng on a
specic problem
IAB reviews and select projects for funding based
on quality and compeRRve process (not
insRtuRon)
Outcomes and innova*on from projects are
jointly owned by the researchers and all
industrial partners


FKUI
Financial Support:
Seed Funding and
Membership Fee
Industrial
Partners (IAB)
-set problems
Federal,
State, and
Lead
University
IUCRC
Center
Consor3um of
Universi3es and
Researchers -
R & D
Research Outcome
Full-scale product and Innova3on
manufacturing
IUCRC for a Specic Industrial Interest

FKUI

FKUI

FKUI
GETTING THE BEST

1.
Hire people more talented than yourself
2.
Talented people attract talented people
3.
Look for the best in each person
4.
Set standards for selection
5.
Spend time evaluating and acculturating

prospective team members
6.
Do not prolong consideration of people who will

not receive a position
As taught by
Theodore
Roosevelt
and
Jack Welch
FKUI
7.
Ceaselessly search for new talent
8.
Ruthlessly replace individuals who do not meet

the standards of the enterprise
9.
Work with the tools at hand

THE ROAD AHEAD

Let us humans surprise the new
millennium
Let us prepare to face it with a beIer and
ner understanding of leadership
Let us develop new methods and be beIer
ci3zens of this world
FKUI
GREAT LEADERS ARE DREAMERS

There is always a dream in all
enterprise, but the dream if it lasts, one
day becomes a reality
Jean Monnet [One Europe, One World]
India must be able to face Britain as an

equal na3on, and not as a subordinate
colony. India could not, and should not,
remain a Bri3sh possession.
FKUI
Mahatma Gandhi
Bung Karno Bermimpi Indonesia Merdeka dan

Berkata Gantunglah Impian Anda seRnggi
BINTANG2 Di Langit
Supaya Impian TERLAKSANA
harus ada 5 Komponen
1.
2.
3.
4.
5.
Harus ada yang MIMPI

Harus ada PEMIMPIN
Harus ada MANAGER
Harus ada FINANCIER
Harus ada PRAJURIT2
yang melaksanakan
FKUI
What about Indonesia ??

We have to set prioriRes in a mulRcomplex
environment, which are as folllows:

1. Educa3on and Health for the populaRon
2. Innova3on through R&D by increasing the budget to
achieve 1% of GDP in 2017
3. Infrastructure and SCIENCE PARKS has to be
developed
4. CLEAN Energy, Biofuel, Solar/Wind/Nuclear/Hydro/
energy must be developed
5. ICT, Nano, Robo3cs, Biotechnology, Gene3c
engineering and STEM CELLS RESEARCH is a must, etc.
FKUI

FKUI

FKUI

Dr. Boen

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Dr. Boen

Uploaded by

Copyright:

Available Formats

Entrepreneurship

Opportuni3es for the Health Care

Boenjamin Setiawan, dr, PhD.

Entrepreneurship in Health Care

23 February, 2016, CIMB

BS, ppt, Entrepreneurship, Kalbe Farma,

Short History of Kalbe Farma

Entrepreneurship in Health Care

28 Febr, 2016, Workshop ILUNI

Entrepreneurship in Health Care

DistribuRon Network developed so fast that by 1974 (8 years

28 Febr, 2016, Workshop ILUNI

Entrepreneurship in Health Care

10 Companies that started in a garage

Amazon, started by Je Bezos

Apple started in 1976 by

Steve Jobs and Steve Wozniak

founded Amazon.com in 1994

28 Febr, 2016, Workshop ILUNI

Entrepreneurship in Health Care

Entrepreneurship in Health Care

28 Febr, 2016, Workshop ILUNI

Entrepreneurship in Health Care

Key Success Factors of Kalbe Farma

Entrepreneurship in Health Care

Filoso Perusahaan Kunci Menuju Sukses

Falsafah perusahaan merupakan dasar existensi dan sudah

1. Tujuan perusahaan adalah Survival through Growth

3. Perusahaan mampu survive karena: Kwalitas SDM

5. Menganut strategi Par3cipa3ve and Professional

Panca Srada Kalbe Farma 1966-2009

Kalbe harus Survive dengan TUMBUH KEMBANG terus menerus

SDM: Manusia DJITU, PBFWUSSI merupakan Kunci Utama untuk dapat

Inovasi IPTEK merupakan KUNCI KEMAJUAN dan Survival

Manajemen Par3sipa3f dan Profesional adalah keharusan untuk

28 Febr, 2016, Workshop ILUNI

Entrepreneurship in Health Care

Panca Srada Kalbe Farma 2009 now

Trust is the glue

28 Febr, 2016, Workshop ILUNI

key to our success

Entrepreneurship in Health Care

What were the Reasons for Success??

In 1977 within 11 years, the Company was able to

Entrepreneurship in Health Care

Faktor UTAMA yang menentukan Kemajuan

Entrepreneurship in Health Care

Entrepreneurship in Health Care

MANUSIA PBFWUSSI (The 8th Habit

of Highly Eectve People, Stephen R.Covey)

28 Febr, 2016, Workshop ILUNI

Entrepreneurship in Health Care

Entrepreneurship in Health Care

Entrepreneurial Traits (1)

1. InnovaRve & Looking for Opportuni3es

28 Febr, 2016, Workshop ILUNI

Entrepreneurship in Health Care

Entrepreneurial Traits (2)

Entrepreneurship in Health Care

Dierence Between Entrepreneurship

Entrepreneurship in Health Care

Entrepreneurship in Health Care